Quote from newwurldmn:
Short straddle and short Iron Condor are expressing two different views (though the views are similar in that they both are betting on muted volatility). What matters is the strikes you are short. If you are short wide strikes in iron condors you will have a different risk profile than if you are short narrow strikes.
Specifically regarding VVUS, earnings are irrelevant. The company doesn't even have a product yet. There is an FDA Advisory Panel soon and then an FDA decision on whether Qnexa (a diet pill for morbidly obese people) can be marketed. It's controversal for a lot fo reasons, I can explain over PM but bottom line is stay away if you don't have insight in this. VVUS could be a 5 or 25 stock... I made up the upper level.
Quote from dbh21:
What different views? Aren't both an expression of decreasing vol within a given range - one just has more/some protection than the other?
I definitely have no insight - have read all the news, and don't have an informed opinion. My wife works with the FDA and says they are very very conservative under the current administration.
I was actually thinking a small covered call might work with this stock. The premium is high, and if it drops, the FDA meeting is not final, so there is a good chance for the further trials to work out well in the future. Definately would not be a large position...
Thanks
Apr options should trade tomorrow. If their IV is toward the 150% of JUne rather than up in the 200's, you might be able to construct a double diagonal of sorts that captures IV contraction and isn't whacked too hard if the short strikes are breached.Quote from dbh21:
I am looking at an IC for VVUS which has earnings in a week. The stock trades at $12, and the IV according to TOS for March options is 248% (following month is 150%).